ANI Pharmaceuticals Correlations

ANIP Stock

USD 64.91 0.37 0.57%

The current 90-days correlation between ANI Pharmaceuticals and Everus Construction Group is 0.16 (i.e., Average diversification). The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

ANI Pharmaceuticals Correlation With Market

Weak diversification

The correlation between ANI Pharmaceuticals and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with ANI Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

Moving together with ANI Stock

0.66	XNCR	Xencor Inc Downward Rally	Pair Corr
0.66	CVS	CVS Health Corp	Pair Corr

Moving against ANI Stock

0.84	ALVO	Alvotech	Pair Corr
0.59	MIRA	MIRA Pharmaceuticals,	Pair Corr
0.54	GRFS	Grifols SA ADR	Pair Corr
0.42	GSK	GlaxoSmithKline PLC ADR	Pair Corr
0.42	GNFT	Genfit SA Downward Rally	Pair Corr
0.59	ANRO	Alto Neuroscience,	Pair Corr
0.59	INFU	InfuSystems Holdings	Pair Corr
0.58	ADUS	Addus HomeCare	Pair Corr
0.55	SNDA	Sonida Senior Living	Pair Corr
0.52	BIIB	Biogen Inc	Pair Corr
0.5	DH	Definitive Healthcare	Pair Corr
0.47	NVST	Envista Holdings Corp	Pair Corr
0.43	SYRE	Spyre Therapeutics	Pair Corr
0.36	SEER	Seer Inc	Pair Corr

Related Correlations Analysis

	ECG	FMC	DAO	ACLS	GFF
ECG		0.58	0.69	0.93	0.42	ECG
FMC	0.58		0.38	0.66	0.42	FMC
DAO	0.69	0.38		0.6	0.14	DAO
ACLS	0.93	0.66	0.6		0.54	ACLS
GFF	0.42	0.42	0.14	0.54		GFF
	ECG	FMC	DAO	ACLS	GFF

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between ANI Stock performing well and ANI Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ANI Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ECG	2.51	0.77	0.29	0.64	2.21	(3.09)	6.46	(4.07)	20.95
FMC	2.24	0.00	0.01	0.10	3.11	(2.52)	4.64	(4.96)	17.97
DAO	2.11	0.14	0.04	0.29	2.64	(2.21)	5.55	(3.88)	13.25
ACLS	2.90	0.48	0.14	0.37	3.56	(3.14)	6.46	(5.43)	22.10
GFF	1.85	0.03	0.02	0.12	2.32	(1.95)	4.44	(3.65)	15.07

ANI Pharmaceuticals Corporate Management

Meredith Cook	General VP	Profile
Elizabeth JD	Chief Disease	Profile
Krista Davis	Senior Officer	Profile
Muthusamy RPh	COO RD	Profile
Thomas Rowland	Senior Brands	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC